SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-18-018114
Filing Date
2018-07-31
Accepted
2018-07-31 16:16:12
Documents
3
Period of Report
2018-07-31
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K abio-8k_20180731.htm 8-K 28441
2 EX-99.1 abio-ex991_7.htm EX-99.1 19675
3 GRAPHIC grwlfzkd4yo3000001.jpg GRAPHIC 20861
  Complete submission text file 0001564590-18-018114.txt   78297
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22873 | Film No.: 18981290
SIC: 2835 In Vitro & In Vivo Diagnostic Substances